$OCGN
Ocugen, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Malvern, PA
OCGN chart
What traders are saying about $OCGN
Latest postsOcugen, Inc. news
- Ocugen Sets November 4 Earnings Report as Gene Therapy Advances
MyChesCo ·
- Ocugen Inc. stock rises Tuesday, outperforms market
MarketWatch ·
- Noble Financial keeps USD 12.00 target for Ocugen stock
ad-hoc-news.de ·
- Ocugen introduces master regulator gene approach in novel blindness treatment initiative
Traders Union ·
- Ocugen's Friday Slide Says Little; the November 4 Filing and a Conditional MENA Deal Say More
ad-hoc-news.de ·
- Ocugen's 2027 Readout Is the Real Test, Not Friday's 7.9% Slide
ad-hoc-news.de ·
- Ocugen Sets November 4 for Q3 Update as Shareholders Weigh a 250 Million Share Request
ad-hoc-news.de ·
- Ocugen's MENA Licence, Phase 3 Enrolment and a 250 Million Share Request Answer Three Different Ques
ad-hoc-news.de ·
- Ocugen's Pipeline, Its Contract Terms and Its Share Count Are Three Separate Questions
ad-hoc-news.de ·
- Ocugen Inc. stock falls Thursday, underperforms market
MarketWatch ·
- Ocugen Sets October Record Date as Investors Weigh Share Authorization Against 2027 Clinical Readout
ad-hoc-news.de ·
- Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
Yahoo Finance ·
Ocugen, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.4M | $4.1M | $6.0M | $2.5M |
| Net income | -$68.0M | -$54.0M | -$63.0M | -$86.8M |
| Diluted EPS | – | – | $-0.26 | $-0.40 |
| Total assets (year end) | $43.5M | $82.4M | $64.5M | $108.6M |
| Cash and equivalents (year end) | $18.6M | – | $39.5M | $77.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ocugen, Inc.
- Ticker
- OCGN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Malvern, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1372299
- Former names
- HISTOGENICS CORP
Frequently asked questions
What exchange is Ocugen, Inc. listed on?
Ocugen, Inc. trades on the Nasdaq under the ticker symbol OCGN.
What industry is Ocugen, Inc. in?
Ocugen, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Ocugen, Inc. headquartered?
Ocugen, Inc.'s business address on file with the SEC is in Malvern, PA.
When does Ocugen, Inc.'s fiscal year end?
Ocugen, Inc.'s fiscal year ends on December 31.
How much revenue did Ocugen, Inc. report?
Ocugen, Inc. reported $4.4M in revenue for calendar year 2025, according to its SEC filings.